China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
1.290
+0.040 (3.20%)
At close: Jan 6, 2026, 4:00 PM EST
1.290
0.00 (0.00%)
After-hours: Jan 6, 2026, 4:10 PM EST
China Pharma Holdings Revenue
China Pharma Holdings had revenue of $756.22K in the quarter ending September 30, 2025, a decrease of -31.26%. This brings the company's revenue in the last twelve months to $4.05M, down -26.92% year-over-year. In the year 2024, China Pharma Holdings had annual revenue of $4.53M, down -35.41%.
Revenue (ttm)
$4.05M
Revenue Growth
-26.92%
P/S Ratio
0.98
Revenue / Employee
$18,090
Employees
224
Market Cap
6.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.53M | -2.48M | -35.41% |
| Dec 31, 2023 | 7.01M | -1.09M | -13.48% |
| Dec 31, 2022 | 8.10M | -1.54M | -15.95% |
| Dec 31, 2021 | 9.64M | -1.22M | -11.27% |
| Dec 31, 2020 | 10.87M | -57.49K | -0.53% |
| Dec 31, 2019 | 10.92M | -1.41M | -11.41% |
| Dec 31, 2018 | 12.33M | -881.63K | -6.67% |
| Dec 31, 2017 | 13.21M | -2.36M | -15.15% |
| Dec 31, 2016 | 15.57M | -4.78M | -23.49% |
| Dec 31, 2015 | 20.35M | -1.78M | -8.05% |
| Dec 31, 2014 | 22.13M | -10.67M | -32.53% |
| Dec 31, 2013 | 32.81M | -21.70M | -39.81% |
| Dec 31, 2012 | 54.51M | -26.66M | -32.85% |
| Dec 31, 2011 | 81.17M | 6.78M | 9.11% |
| Dec 31, 2010 | 74.39M | 12.69M | 20.57% |
| Dec 31, 2009 | 61.70M | 10.73M | 21.05% |
| Dec 31, 2008 | 50.97M | 17.78M | 53.58% |
| Dec 31, 2007 | 33.19M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
CPHI News
- 9 months ago - China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split - PRNewsWire
- 1 year ago - China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with Streeterville - PRNewsWire
- 1 year ago - China Pharma Announces the Entry of "At-The-Market" Equity Offering - PRNewsWire
- 1 year ago - China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025 - PRNewsWire
- 2 years ago - China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split - PRNewsWire
- 2 years ago - China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device - PRNewsWire
- 2 years ago - China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs - PRNewsWire
- 3 years ago - China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask - PRNewsWire